Description
Enasidenib mesylate (AG-221 mesylate) is a potent and selective IDH2 mutase inhibitor that promotes differentiation of leukemia myeloid cells for the treatment of acute myeloid leukemia.
Molecular Formula
C20H21F6N7O4S
Smiles
CS(O)(=O)=O.CC(C)(O)CNC1NC(NC2CCNC(C2)C(F)(F)F)NC(N1)-C1CCCC(N1)C(F)(F)F
Storage
Powder: -20℃ for 3 years. In solvent: -80℃ for 1 year.
Solubility Information
DMSO: 80 mg/mL (140.48 mM), Sonication is recommended.